Pharmacotherapy Specialty Core Therapeutic Module Package for Recertification (Cert # L219275)

ACPE Numbers: Various – see listing below
Pre-Sale Date: 10/27/2021
Content Release Date: 11/24/2021
Expiration Date: 11/22/2022
Activity Type: Application-based
CE Credits: 5.0 (BPS and ACPE) contact hours
Activity Fee: $100 (ASHP member); $150 (non-member)

Activity Overview

The Core Therapeutic Modules for Recertification Package consists of 5 activities (see table below). In each activity, faculty review clinical topics and practice skills using a case-based approach. This package is intended for board certified pharmacists in need of recertification credit; the activities were designed based on the content outline developed by the Board of Pharmacy Specialties (BPS). 

Each activity is approved for 1.0 contact hour of continuing pharmacy education credit. Successful completion of all the learning modules will provide up to 5.0 contact hours of continuing pharmacy education credit.

 The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

These activities are intended for Board Certified Pharmacotherapy Specialists in need of recertification credit. 

Board certified pharmacists are eligible to receive 5.0 contact hours of recertification credit for completing this module. To earn recertification credit, learners must review the activity content and successfully complete the online assessment by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment. 

Participants who pass the assessments will be eligible for recertification credit in the year in which the assessment was completed. 

These activities are part of the ASHP professional development program for BCPS recertification approved by the BPS. 

Learning Activity

ACPE Number

Contact Hours

Select Topics in Psychiatric Disorders

0204-0000-21-625-H01-P

1 ACPE

Select Topics in Rheumatology

0204-0000-21-626-H01-P

1 ACPE

Heart Failure

0204-0000-21-627-H01-P

ACPE

Selected Topics in Renal Disease

0204-0000-21-628-H01-P

1 ACPE

Patient Education and Health Literacy

0204-0000-21-629-H04-P

1 ACPE

  →   Recertification Assessment: Core Therapeutic Modules (77% passing score required)

5 BPS

After participating in these CPE activities, learners should be able to:

Select Topics in Psychiatric Disorders
ACPE #: 0204-0000-21-625-H01-P

For patients with bipolar, schizophrenia, anxiety disorders, post-traumatic stress disorder, and/or substance abuse disorder:

  • Interpret basic diagnostic factors, clinical presentation, and target symptoms of selected psychiatric disorders.
  • Formulate the most appropriate treatment, monitoring, and follow-up plans based on patient-specific information and current guidelines.
  • Evaluate drug-related problems and response to therapy. 

Select Topics in Rheumatology
ACPE #: 0204-0000-21-626-H01-P

For patients with rheumatoid arthritis, osteoarthritis and gout:

  • Formulate the most appropriate treatment and monitoring, based on drug-specific variables, patient-specific information and clinical practice guidelines.
  • Evaluate drug-related problems and response to therapy.
  • Recommend appropriate modifications of patient-specific treatment plans based on follow up assessment. 

Heart Failure
ACPE #: 0204-0000-21-627-H01-P

  • Interpret diagnostic and/or laboratory tests, vital signs and clinical presentation in patients with heart failure.
  • Formulate the most appropriate treatment and monitoring plans, based patient-specific information and current guidelines for patients with heart failure.
  • Recommend appropriate modifications of patient-specific treatment plans based on follow up assessment in patients with heart failure. 

Selected Topics in Renal Disease
ACPE #: 0204-0000-21-628-H01-P

  • For patients with acute kidney injury and chronic kidney disease determine the most appropriate treatment and monitoring based on drug characteristics, patient-specific factors, and current clinical practice guidelines.
  • Manage drug dosing and drug-related complications in patients receiving renal replacement therapy.
  • Identify appropriate modifications to the treatment plans based on follow-up assessment to optimize outcomes. 

Patient Education and Health Literacy
ACPE #: 0204-0000-21-629-H04-P

  • Assess considerations for communicating pharmacotherapy plans to various patient populations, including pediatric patients and geriatric patients, using universal health literacy precautions.
  • Evaluate methods for educating patients and caregivers on safe and appropriate use of medications and devices.

Faculty bios

Christopher Betz, Pharm.D., BCPS, FKSHP, FASHP*
Associate Professor, Clinical and Administrative Sciences
Sullivan University College of Pharmacy
Louisville, Kentucky 

Snehal H. Bhatt, Pharm.D., BCPS-AQ Cardiology, FASHP, AACC*
Associate Professor of Pharmacy Practice
Massachusetts College of Pharmacy and Health Sciences
Clinical Pharmacist
Beth Israel Deaconess Medical Center
Boston, Massachusetts 

Ilya Danelich, Pharm.D., BCPS, BCCP
Clinical Coordinator; Cardiology Clinical Pharmacy Specialist
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania

Jessica Farrell, Pharm.D.
Associate Professor
Albany College of Pharmacy and Health Sciences
Clinical Pharmacist
The Center for Rheumatology
Albany, New York 

Mei T. Liu, Pharm.D., BCPP
Clinical Assistant Professor
Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey
Piscataway, New Jersey
Psychiatry Clinical Pharmacist
Penn Medicine Princeton House Behavioral Health
Princeton, New Jersey 

Nicholas Owens, Pharm.D., BCACP, BCPS
Assistant Professor of Clinical Pharmacy
Philadelphia College of Pharmacy at University of the Sciences
Philadelphia, Pennsylvania 

Douglas Slain, Pharm.D., BCPS, AQ-ID*
Professor and Infectious Diseases Clinical Specialist
West Virginia University (WVU) and WVU Hospitals and Clinics
Canonsburg, Pennsylvania

Laura Waite, Pharm.D., BCPS, CLS, BC-ADM
Associate Professor of Clinical Pharmacy, Director of Student Recruitment and Engagement
Middle States Commission on Higher Education Self-Study Co-Chair
Philadelphia College of Pharmacy
University of the Sciences
Philadelphia, Pennsylvania 

*Content matter experts

Anna M. Jackson, Pharm.D., BCPS
Tony Martin, Pharm.D., M.B.A.
Susan R. Dombrowski, M.S., R.Ph.

Iman Aberra, BCPS
Mohammad Qasim Adil, Pharm.D., BCPS
Junsup (Justin) Ahn, Pharm.D., BCPS
Dawn Anderson, Pharm.D., M.B.A., BCPS
John Austin, Pharm.D., BCPS, BCCCP
Jill Balcombe, Pharm.D., BCPS
Grace Benson, Pharm.D., BCPS
Ethan Blashford, Pharm.D., BCPS
Christina Brummett, Pharm.D., BCPS, BCCCP
Carley Castelein, Pharm.D., BCPS, CPPS
Hetty Cheng, Pharm.D., BCPS
Kevin Chilbert, Pharm.D., BCPS
Lauren Dombrowski, Pharm.D., BCPS
Janine Douglas, Pharm.D., BCPS
Shannon Eidsness, Pharm.D., BCPS
Karly Erickson, Pharm.D., BCPS, BCCCP
Michelle Estevez, Pharm.D., DPLA, BCPS
David Evans, Pharm.D., BCPS
Katherine Evans, Pharm.D., BCPS
Christopher  Garner, B.S.Pharm., BCPS
Carmen Gust, Pharm.D., BCPS
Matt Haldiman, Pharm.D., MBA, BCPS
Coleen Hart, Pharm.D, BCPS, BCCCP
Chris Hayek, Pharm.D., BCPS
Destine Hoover, Pharm.D., BCPS
Jean Huang, Pharm.D., BCPS
James Hummel, Pharm.D., BCPS, CBIS
Kamanski Jordan-Williams, Pharm.D., BCPS
Lairyn Kenney, BS, Pharm.D., BCPS
Eric Kinney, Pharm.D., BCPS
Yvonne  Labram, Pharm.D., BCPS
Jane LeBlond, Pharm.D.
Jennifer Lee, Pharm.D., BCPS, BCCCP
Linda Logan, Pharm.D., BCPS, BCPP, BCACP
Kenzi Lopes-Pimental, Pharm D., BCPS
Erin Mangum, Pharm.D., BCPS
Samuel Martin, Pharm.D., BCPS
Amanda Memken, Pharm.D., BCPS, BCPPS
Clarice Montgomery, Pharm.D. BCPS
Charu Narra, Pharm.D., BCPS
Debra Oliver, Pharm D., BCPS
Monica Owen, Pharm.D., BCPS
Jennifer Panic, Pharm.D., BCPS
Tyler Perry, Pharm.D., BCPS
Kathy Pollitzer, Pharm.D., BCPS
Amina Popoola, Pharm.D., BCPS
Rebecca Powell, Pharm.D., BCPS
Forrest Ridgway, Pharm.D., BCPS, BCOP
Alex Rock, Pharm.D., AAHIVP, BCPS
Kristen Rychalsky, Pharm.D., BCPS, BCOP
Nahirony Sanchez Coronado, Pharm.D., BCPS, BCGP
Aulia Shariat, Pharm.D., BCPS
Caroline Simari, Pharm.D., BCPS
Donald Singh, Pharm.D., MBA, BCPS
pauline situ, Pharm D., BCPS
Mehek Talwar, Pharm.D., BCPS
Amanda Troup, Pharm.D., BCPS
Cortney  Valela , Pharm.D. BCPS
Sarah White, Pharm.D., BCPS
Brittany Williams, Pharm.D., BCPS
Lauren Williams, Pharm.D., BCPS
Angela Wowczuk, Pharm D., BCPS, AAHIVE
Kristen Young, Pharm.D., BCPS
Cella Yung, Pharm.D., BCPS, CDCES
Katrina Zywiec, Pharm.D., BCPS

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual of his or her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring the in the last 12 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content. 

All faculty and planners for ASHP education activities are qualified and selected by ASHP and required to disclose any relevant financial relationships with commercial interests. ASHP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity.

  • Jessica Farrell: Pfizer, speaker bureau; Abbvie, speaker bureau; Cumberland Pharmaceuticals, consultant 

All other planners, presenters, reviewers, ASHP and others with an opportunity to control content report no financial relationships relevant to this activity.

Activities which can be completed in any order. Each activity consists of audio, video, and/or PDFs and evaluations.  Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity. 

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity. 

Development

These activities were developed by ASHP.